Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes

European Heart Journal

Volumn 19, Issue SUPPL.D, 1998, Pages

  Braunwald, E ^a   Maseri, A ^a   Armstrong, P W ^a   Califf, R M ^a   Gibler, W A ^a   Hamm, C W ^a   Simoons, M L ^a   Van de Werf, F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; UNSTABLE ANGINA PECTORIS;

ACETATES; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY DISEASE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RANDOMIZED CONTROLLED TRIALS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; TYROSINE;

EID: 0031920113     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)